Filing Details

Accession Number:
0001140361-15-011412
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-03-11 18:32:24
Reporting Period:
2015-03-09
Filing Date:
2015-03-11
Accepted Time:
2015-03-11 18:32:24
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1048477 Biomarin Pharmaceutical Inc BMRN Pharmaceutical Preparations (2834) 680397820
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1221590 Jacques Jean Bienaime C/O Biomarin Pharmaceutical Inc.
770 Lindaro St.
San Rafael CA 94901
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-03-09 15,000 $12.99 57,279 No 4 M Indirect Shares held by Bienaime Family Trust
Common Stock Disposition 2015-03-09 15,000 $112.12 42,279 No 4 S Indirect Shares held by Bienaime Family Trust
Common Stock Disposition 2015-03-09 4,000 $112.14 38,279 No 4 S Indirect Shares held by Bienaime Family Trust
Common Stock Disposition 2015-03-10 2,021 $114.89 36,258 No 4 S Indirect Shares held by Bienaime Family Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Indirect Shares held by Bienaime Family Trust
No 4 S Indirect Shares held by Bienaime Family Trust
No 4 S Indirect Shares held by Bienaime Family Trust
No 4 S Indirect Shares held by Bienaime Family Trust
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy Common Stock) Disposition 2015-03-09 15,000 $0.00 15,000 $12.99
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
46,500 2006-11-11 2016-05-10 No 4 M Indirect
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 254,757 Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Stock Option (right to buy Common Stock) $12.99 2006-11-11 2016-05-10 10,000 10,000 Indirect
Common Stock Stock Option (right to buy Common Stock) $12.99 2006-11-11 2016-05-10 10,000 10,000 Indirect
Common Stock Stock Option (right to buy Common Stock) $12.99 2006-11-11 2016-05-10 10,000 10,000 Indirect
Common Stock Stock Option (right to buy Common Stock) $12.99 2006-11-11 2016-05-10 10,000 10,000 Indirect
Common Stock Stock Option (right to buy Common Stock) $12.99 2006-11-11 2016-05-10 20,000 20,000 Indirect
Expiration Date Amount Remaning Holdings Nature of Ownership
2016-05-10 10,000 10,000 Indirect
2016-05-10 10,000 10,000 Indirect
2016-05-10 10,000 10,000 Indirect
2016-05-10 10,000 10,000 Indirect
2016-05-10 20,000 20,000 Indirect
Footnotes
  1. The reporting person an his spouse act as trustees for the Bienaime Family Trust
  2. The price in column 4 is an average weighted price. The price actually received ranged from $111.20 to $113.75. The issuing person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the amount of shares sold at each price within the range.
  3. The price in column 4 is an average weighted price. The price actually received ranged from $111.32 to $113.70. The issuing person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the amount of shares sold at each price within the range.
  4. The price in column 4 is an average weighted price. The price actually received ranged from $114.881 to $114.95. The issuing person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the amount of shares sold at each price within the range.
  5. Original option grant cests 6/48ths on November 11, 2006, and 1/48th on the 11th of every month thereafter.
  6. The reporting person's spouse is the trustee of each child's trust.